Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RESI
2051
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $8.14M | ﹤0.01% |
935,850
+23,623
| +3% | +$205K |
|
2052
Kelly Services Class A
KELYA
$481M
| $8.14M | ﹤0.01% |
514,605
+11,727
| +2% | +$185K |
|
2053
Antero Resources
AR
$10.2B
| $8.14M | ﹤0.01% |
3,203,204
+156,484
| +5% | +$397K |
|
2054
PagerDuty
PD
$1.53B
| $8.12M | ﹤0.01% |
283,626
+91,057
| +47% | +$2.61M |
|
2055
Cenovus Energy
CVE
$30.4B
| $8.11M | ﹤0.01% |
1,736,579
+158,482
| +10% | +$740K |
|
2056
Camden National
CAC
$684M
| $8.09M | ﹤0.01% |
234,292
+3,012
| +1% | +$104K |
|
|
TBI
2057
Trueblue
TBI
$179M
| $8.09M | ﹤0.01% |
529,800
-22,996
| -4% | -$351K |
|
2058
Heidrick & Struggles
HSII
$1.03B
| $8.08M | ﹤0.01% |
373,790
-9,757
| -3% | -$211K |
|
2059
Wabash National
WNC
$457M
| $8.08M | ﹤0.01% |
760,688
-12,498
| -2% | -$133K |
|
2060
Signet Jewelers
SIG
$3.73B
| $8.06M | ﹤0.01% |
784,881
+25,799
| +3% | +$265K |
|
2061
Quanex
NX
$661M
| $8.06M | ﹤0.01% |
580,592
-7,791
| -1% | -$108K |
|
2062
Revolution Medicines
RVMD
$8.7B
| $8.06M | ﹤0.01% |
255,160
+134,282
| +111% | +$4.24M |
|
2063
MYR Group
MYRG
$2.73B
| $8.05M | ﹤0.01% |
252,418
+2,877
| +1% | +$91.8K |
|
|
AGEN
2064
Agenus
AGEN
$143M
| $8.04M | ﹤0.01% |
104,265
+24,650
| +31% | +$1.9M |
|
2065
Icahn Enterprises
IEP
$4.67B
| $7.99M | ﹤0.01% |
164,801
+13,501
| +9% | +$655K |
|
|
EGRX
2066
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.97M | ﹤0.01% |
166,037
+11,568
| +7% | +$555K |
|
2067
Northfield Bancorp
NFBK
$492M
| $7.96M | ﹤0.01% |
691,249
+10,819
| +2% | +$125K |
|
|
SHYF
2068
DELISTED
The Shyft Group
SHYF
| $7.95M | ﹤0.01% |
472,228
+6,477
| +1% | +$109K |
|
2069
CRH
CRH
$76.1B
| $7.94M | ﹤0.01% |
231,489
+62,067
| +37% | +$2.13M |
|
2070
RB Global
RBA
$21.7B
| $7.94M | ﹤0.01% |
194,477
+161,866
| +496% | +$6.61M |
|
2071
Corbus Pharmaceuticals
CRBP
$116M
| $7.92M | ﹤0.01% |
31,479
-1,541
| -5% | -$388K |
|
2072
Progyny
PGNY
$1.94B
| $7.92M | ﹤0.01% |
306,944
+93,238
| +44% | +$2.41M |
|
2073
Stoneridge
SRI
$228M
| $7.91M | ﹤0.01% |
382,996
+10,929
| +3% | +$226K |
|
|
KRA
2074
DELISTED
Kraton Corporation
KRA
| $7.89M | ﹤0.01% |
456,866
+9,851
| +2% | +$170K |
|
2075
Quince Therapeutics
QNCX
$85.9M
| $7.88M | ﹤0.01% |
170,126
+35,747
| +27% | +$1.65M |
|